Biotech Company Amabiotics Unveils Rebranding

Amabiotics, a global biotech company developing microbiome-derived medicine for neurological conditions, has announced that it is changing its corporate name to “Stellate Therapeutics”. Founded in 2010, the New York-headquartered company develops small molecules produced by human gut bacteria into what are claimed to be first-in-class personalised therapies for neurological diseases, including Parkinson’s and Alzheimer’s disease. […]
[READ MORE]